Medical device company MedaPhor signs deal to sell instruments in China

Cardiff medical devices company MedaPhor has entered into a new distribution deal that will see its innovative products sold in China. 
The Cardiff University spinout firm, which has received equity backing from Fusion IP, has developed technology that provides medical(cheap medical equipment) students with a training programme that replicates a real ultrasound scanning experience. 
Trainees can feel what they see on the computer screen in order to develop the complex mix of cognitive skills and eye-hand movement co-ordination, but without the need for an ultrasound machine or a patient and with considerably reduced direct supervision by an expert. 
It has now entered into a exclusive distribution agreement with Tellyes Scientific, which will see its range of ultrasound simulators into mainland China. 
Tellyes, a $40m medical simulation manufacturing and distribution business, based in Tianjin in China, has 100 dedicated sales staff. 
As part of the agreement Tellyes is purchasing 10 of MedaPhor’s ScanTrainer systems that will be sited in its five regional offices that cover the whole of China Tellyes will be targeting China’s 3,000 nursing schools, medical colleges and universities. 
Since spinning out of Cardiff University, MedaPhor has established sales in the UK, Europe, Australia and the US and recently expanded its ScanTrainer range with its new transabdominal simulator, aimed at the large obstetrics and gynaecology, general medical, and emergency medicine markets. 
Fusion has a 39% shareholding in MedaPhor. 
Chief executive of Tellyes, Simon Liu said: “We are very excited about the newly-formed strategic partnership with MedaPhor, whose ultrasound(portable ultrasound machine) simulators are great additions to what Tellyes is currently offering to the Chinese hospitals and medical schools.” 
Stuart Gall, chief executive of MedaPhor, said: “We are delighted to be working with Tellyes to target the huge and growing Chinese medical simulation market and we look forward to working with Simon and his team, as we launch our range of ScanTrainer simulator systems into China.” 
Chief executive of Fusion IP, David Barnes, said: “This is a major development for MedaPhor and we are excited about the potential of the Chinese market for MedaPhor’s superb ultrasound simulator. 
MedaPhor is now generating sales in all the major global medical markets and we look forward to its continued growth.”